QuidelOrtho Completes Acquisition of LEX Diagnostics

QuidelOrtho Corporation, a global leader in in vitro diagnostics, has successfully completed its acquisition of LEX Diagnostics. This strategic move is expected to enhance QuidelOrtho's capabilities and market position within the diagnostics sector. The integration of LEX Diagnostics' assets and expertise is anticipated to drive innovation and expand the company's product offerings. This acquisition underscores QuidelOrtho's commitment to growth and its strategy of consolidating key players in the rapidly evolving field of diagnostic solutions.